ESPR R&D Expense Growth
Esperion Therapeutics Inc · R&D Expense Growth
ESPR R&D Expense Growth
Latest reported-35.46%period ending
ESPR Quarterly R&D Growth (QoQ) (0.00% → -35.46%)
Latest values, visible window
High-resolution chart · PNG
ESPR r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -35.4589% | |
| -1.4507% | |
| 95.2335% | |
| -42.3588% | |
| 14.3937% | |
| 5.5785% | |
| -9.2837% | |
| -14.4893% | |
| -24.4561% | |
| 19.1938% | |
| -32.644% | |
| -29.5784% | |
| -5.0011% | |
| 13.348% | |
| -10.1412% | |
| 33.3607% | |
| -11.9387% | |
| 9.0206% | |
| 1.025% | |
| -10.3026% | |
| -33.3858% | |
| 18.9355% | |
| 0.846% | |
| 0.8213% | |
| -9.2379% | |
| -20.8094% | |
| 12.8377% | |
| -7.6013% | |
| -6.3974% | |
| 19.0657% | |
| 5.1285% | |
| -3.4587% | |
| 22.4319% | |
| -16.5194% | |
| 4.727% | |
| 6.6592% | |
| 44.126% | |
| 84.331% | |
| 39.1833% | |
| -0.9499% | |
| 23.0644% | |
| 9.7834% | |
| 0.5271% | |
| -2.4493% | |
| 19.1935% | |
| -13.5768% | |
| 9.8958% | |
| 20.8889% | |
| -26.4157% | |
| 110.7151% | |
| 12.329% | |
| 48.1617% | |
| 26.4955% | |
| -32.6545% | |
| 5.4153% | |
| 49.6408% | |
| 0% | |
| -28.683% | |
| 14.8718% | |
| 9.375% | |
| -7.8287% | |
| -7.8598% | |
| 3.0324% | |
| 10.7552% | |
| 5.0796% | |
| -9.0707% | |
| -3.8009% | |
| 13.8562% | |
| -26.5483% | |
| 9.7985% | |
| 50.196% | |
| 0% |